Filing Details
- Accession Number:
- 0001209191-23-016105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-03-03 21:30:57
- Reporting Period:
- 2023-03-01
- Accepted Time:
- 2023-03-03 21:30:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1718852 | Prometheus Biosciences Inc. | RXDX | Pharmaceutical Preparations (2834) | 814282653 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1749623 | C. Mark Mckenna | C/O Prometheus Biosciences, Inc. 3050 Science Park Road San Diego CA 92121 | Chairman, President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-03-01 | 700 | $3.70 | 55,844 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-01 | 700 | $125.26 | 55,144 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2023-03-03 | 10,620 | $3.70 | 65,764 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-03-03 | 10,620 | $125.13 | 55,144 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-03-01 | 700 | $0.00 | 700 | $3.70 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2023-03-03 | 10,620 | $0.00 | 10,620 | $3.70 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 492,345 | 2030-12-17 | No | 4 | M | Direct | |
| 481,725 | 2030-12-17 | No | 4 | M | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- 25% of the shares subject to the option vested and became exercisable on November 5, 2021, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Report Person's continued service with the Issuer through each vest date.
Billionaire Hedge Funds
